# Alzamend Neuro, Inc.: Form SCHEDULE 13D/A, filed Oct 7, 2025

- Company: [Alzamend Neuro, Inc.](/companies/alzn.md) (CIK 1677077)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-07
- Accepted by EDGAR: Oct 7, 2025, 21:53 ET
- Period: not reported
- Accession: 0001214659-25-014750
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014750/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014750/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1677077/000121465925014750/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001214659-25-014750. Last ingested by Listed: Nov 11, 2026, 01:45 ET. No prices; not investment advice.
